Epidemic in pandemic: Fungal sinusitis in COVID-19.
J Family Med Prim Care
; 11(2): 807-811, 2022 Feb.
Article
in English
| MEDLINE | ID: covidwho-1776481
ABSTRACT
Objective:
To describe the clinical pattern of invasive fungal sinusitis in COVID-19 and post-COVID-19 cases.Methods:
All patients affected by COVID-19 or having a history of COVID-19 infection with an invasive fungal lesion (mucormycosis/aspergillosis) of the paranasal sinuses, orbit, palate, brain, lung, skin/cheek, and dental has been evaluated for possible description in tertiary care hospital in May 2021.Results:
Twenty-four patients presented with clinical signs and symptoms of fungal infection with a history of COVID-19. Paranasal sinuses were involved in all patients. Palatal involvement was seen in seven cases. Intraorbital extension was seen in 13 cases. Intracerebral involvement was seen in three cases. Comorbid type 2 diabetes was seen in 20 patients. The use of steroids was noticed in 16 cases. Our observation revealed that uncontrolled diabetes, overuse of steroids, increased ferritin levels, and low hemoglobin percentage are the main factors aggravating mucormycosis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Language:
English
Journal:
J Family Med Prim Care
Year:
2022
Document Type:
Article
Affiliation country:
Jfmpc.jfmpc_1352_21
Similar
MEDLINE
...
LILACS
LIS